Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR | Market Cap | 4.39M +24.9% |
| Revenue (ttm) | 30.56M +74.3% |
| Net Income | 1.04M |
| EPS | 0.00 |
| Shares Out | 499.41M |
| PE Ratio | 2.93 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,726,347 |
| Open | 0.0088 |
| Previous Close | 0.0088 |
| Day's Range | 0.0086 - 0.0090 |
| 52-Week Range | 0.0030 - 0.3050 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 18, 2026 |
About Fidia
Fidia S.p.A., together with its subsidiaries, production and sale of numerical controls and software, high-speed milling systems and after-sales technical assistance. The company offers HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. It also provides software solutions incl... [Read more]
Financial Performance
Financial StatementsNews
Scholar Rock's ISEMBYLD Wins FDA Approval As First Muscle-Targeted Therapy For SMA
(RTTNews) - Scholar Rock (SRRK) announced that the U.S. Food and Drug Administration approved ISEMBYLD (apitegromab-mstn) for the treatment of spinal muscular atrophy (SMA) in adults and children two ...
US declares end to lettuce parasite outbreak that killed 2
US health authorities on Friday declared the nation’s largest recorded cyclosporiasis outbreak over, after contaminated iceberg lettuce sickened thousands, though the FDA said it was still probing ...
Scholar Rock (SRRK) Gains FDA Approval for Isembyld Amid High Price-to-Sales Valuation
Scholar Rock (SRRK) Gains FDA Approval for Isembyld Amid High Price-to-Sales Valuation
Pharming Gets FDA Approval For Joenja In Children With APDS
(RTTNews) - Pharming Group N.V. (PHARM.AS) said the U.S. Food and Drug Administration has approved Joenja (leniolisib) for children aged 4 to 11 years with activated phosphoinositide 3-kinase delta sy...
Two bogus doctors caught in Pune; FIRs filed after civic body raid
Pune PMC anti-quackery raids catch two bogus doctors in Kharadi and Warje; FIRs filed, drugs and documents seized, FDA to take further action.
Weekly Buzz: JNJ Wins FDA Nod; AXGN, HCWB Strike Deals; ROIV, AZN, GPCR Lead Clinical Trials
(RTTNews) - Biotech and healthcare saw regulatory approvals, strategic partnerships, M&A activity, and a steady stream of clinical trial updates driving investor attention.
New FDA Drug Approvals - August 2026
(RTTNews) - The U.S. Food and Drug Administration (FDA) granted approval to 13 drugs last month, comprising both new drug approvals and expanded indications for previously approved therapies.
Maharashtra FDA seizes unsafe dairy products, suspends 404 licences in 3-month crackdown
Maharashtra's Food and Drug Administration seized unsafe dairy products valued at Rs 5.4 crore. The agency also suspended 404 licenses during a recent three-month enforcement drive. Inspections covere...
Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay
Exelixis stock dropped out of a buy zone Friday after the FDA delayed the potential approval of its new colon cancer treatment.
Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) — via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within...
Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA
• Company gains further clarity on the additional information required to advance its PMA review • FDA did not request an additional clinical trial following its 100-day review of the PMA application ...
Lundbeck Secures FDA Orphan Drug Designation For Asedebart In Cushing's Syndrome
(RTTNews) - Lundbeck A/S announced that the U.S. FDA has granted Orphan Drug Designation to its investigational antibody Asedebart (Lu AG13909) for the treatment of endogenous Cushing's syndrome.
Shoulder Innovations (SI) Gains FDA Clearance for N-22 Humeral Head Amid Mixed Market Signals
Shoulder Innovations (SI) Gains FDA Clearance for N-22 Humeral Head Amid Mixed Market Signals
PET water bottles 'safe' to drink from, FDA assures
The Food and Drug Administration (FDA) has confirmed that PET bottled water is safe to drink despite online claims that bottles stored in cars or left in the sun can cause cancer.
Biohaven (BHVN) Shares Fall 15% After FDA Partial Hold; Insider Buying and Guru Interest Signal ...
Biohaven (BHVN) Shares Fall 15% After FDA Partial Hold; Insider Buying and Guru Interest Signal Long-Term Potential
‘Chewed tobacco while preparing food’: FDA suspends licence of vada pav seller, five others over hygiene issues in Mumbai
Mumbai FDA suspends licences of six food outlets, including Gajanan Vadapav, over hygiene lapses; raids in Thane seize 28,955 kg food stock worth Rs 20 lakh.
Outlook Therapeutics Highlights LYTENAVA FDA Approval And U.S. Commercial Opportunity
(RTTNews) - Outlook Therapeutics, Inc. (OTLK), a biopharmaceutical company focused on retinal diseases, announced that Chief Executive Officer Bob Jahr participated in a Virtual Investor CEO Connect s...
Maharashtra FDA raids 11 food units in Thane, seizes 28,955kg raw materials, food products worth Rs 20.48 lakh
Maharashtra FDA raided 11 food manufacturing units in Thane's Shil-Diva area. They seized raw materials and finished food products valued at over twenty lakh rupees. Over twenty-eight thousand kilogra...
Prelude Therapeutics Receives FDA Clearance For PRT13722 IND In HR+/HER2-Breast Cancer
(RTTNews) - Prelude Therapeutics Incorporated (PRLD), a precision oncology company, announced that the U.S. FDA has cleared its IND application for PRT13722.
Prelude Therapeutics (PRLD) Gains FDA Nod for Phase 1 Trial in Breast Cancer
Prelude Therapeutics (PRLD) Gains FDA Nod for Phase 1 Trial in Breast Cancer
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials of its experimental epilepsy drug after rodent findings, sending its shares down mo...
Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP
Palantir Bulls Face a Reality Check Before EarningsInovio Pharmaceuticals (NASDAQ:INO) is approaching an October 30 PDUFA date for INO-3107, its lead DNA medicine candidate for recurrent respiratory p...
Rezolute (RZLT) FDA Review Highlights Uncertain Path Amid Cash-Flow Challenges
Rezolute (RZLT) FDA Review Highlights Uncertain Path Amid Cash-Flow Challenges
After TOI report, FDA deputes 22 officers to plug food safety gaps
Gurgaon Issued Two Dedicated Officers; Postings Effective For 180 Days
Clinical Catalysts Drive Biotech Movers: Opus Genetics, Quantum & More
(RTTNews) - Biotech and medical device stocks saw notable moves Wednesday, led by Opus Genetics, which surged more than 27% following positive clinical data. Quantum BioPharma gained after receiving F...